OSA Stock Price, ProSomnus, Inc. Quote, Chart

Market Summary

USD0.140.00

Market Closed

0.00%

OSA Stock Price

View Fullscreen

OSA RSI Chart

OSA Valuation

Market Cap

2.4M

Price/Earnings (Trailing)

-0.1

Price/Sales (Trailing)

0.09

EV/EBITDA

-0.96

Price/Free Cashflow

-0.14

OSA Price/Sales (Trailing)

OSA Profitability

Operating Margin

50.67%

EBT Margin

-54.31%

Return on Equity

-9.7K%

Return on Assets

-91.66%

Free Cashflow Yield

-722.5%

OSA Fundamentals

OSA Revenue

Revenue (TTM)

27.7M

Rev. Growth (Yr)

35.33%

Rev. Growth (Qtr)

10.84%

OSA Earnings

Earnings (TTM)

-24.1M

Earnings Growth (Yr)

-411.05%

Earnings Growth (Qtr)

38.88%

Breaking Down OSA Revenue

Last 7 days

-77.4%

Last 30 days

-81.2%

Last 90 days

-81.5%

How does OSA drawdown profile look like?

OSA Financial Health

Current Ratio

1

Debt/Equity

48.92

Debt/Cashflow

-1.33

OSA Investor Care

Shares Dilution (1Y)

8.43%

Diluted EPS (TTM)

-1.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	21.5M	23.5M	25.6M	27.7M
2022	15.4M	16.7M	18.1M	19.4M
2021	0	0	0	14.1M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of ProSomnus, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 15, 2024	dow brian b	acquired	-	-	315,742	chief financial officer
Feb 15, 2024	liptak len	acquired	-	-	1,322,760	chief executive officer
Feb 15, 2024	kim sung	acquired	-	-	315,742	chief technical officer
Oct 16, 2023	dow brian b	acquired	-	-	93,750	chief financial officer
Oct 16, 2023	rikkers laing	acquired	-	-	192,500	-
Oct 16, 2023	rikkers laing	sold (taxes)	-70,131	0.855	-82,025	-
Oct 16, 2023	liptak len	acquired	-	-	168,750	chief executive officer
Oct 16, 2023	kim sung	acquired	-	-	93,750	chief technical officer

Which funds bought or sold OSA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	Presidio Capital Management, LLC	unchanged	-	-8,224	11,380	0.01%
Apr 24, 2024	Root Financial Partners, LLC	sold off	-100	-61,787	-	-%
Apr 15, 2024	LPWM LLC	unchanged	-	-13,533	38,032	0.01%
Mar 22, 2024	PNC FINANCIAL SERVICES GROUP, INC.	new	-	7,508	7,508	-%
Mar 11, 2024	VANGUARD GROUP INC	added	34.52	21,142	100,081	-%
Feb 15, 2024	B. Riley Asset Management, LLC	sold off	-100	-4,463	-	-%
Feb 14, 2024	Walleye Trading LLC	new	-	11,284	11,284	-%
Feb 14, 2024	K2 PRINCIPAL FUND, L.P.	sold off	-100	-5,917	-	-%
Feb 14, 2024	Polar Asset Management Partners Inc.	unchanged	-	-6,374	5,802	-%
Feb 14, 2024	Polar Asset Management Partners Inc.	reduced	-10.28	-69,244	379,212	0.01%

Are Funds Buying or Selling OSA?

Are funds buying OSA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own OSA

No. of Funds

Unveiling ProSomnus, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	walleye capital llc	6.31%	1,103,690	SC 13G
Feb 12, 2024	polar asset management partners inc.	3.8%	638,596	SC 13G/A
Dec 08, 2023	smc holdings ii, lp	36.6%	9,327,557	SC 13D/A
Oct 23, 2023	smc holdings ii, lp	11.7%	2,130,630	SC 13D

Recent SEC filings of ProSomnus, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 25, 2024	25-NSE	25-NSE
Apr 19, 2024	8-K	Current Report
Apr 18, 2024	8-K	Current Report
Mar 27, 2024	10-K	Annual Report
Mar 26, 2024	8-K	Current Report
Mar 22, 2024	8-K	Current Report
Feb 16, 2024	4	Insider Trading
Feb 16, 2024	3/A	Insider Trading
Feb 16, 2024	3/A	Insider Trading
Feb 16, 2024	3/A	Insider Trading

Peers (Alternatives to ProSomnus, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.5B	40.1B	-5.27%	-1.83%	32.59	4.65	-8.12%	-17.45%
BDX	66.9B	19.5B	-6.10%	-12.08%	53.25	3.43	4.02%	-22.04%
ALGN	23.2B	3.9B	-5.77%	-2.75%	52.14	6.01	3.42%	23.09%
BAX	20.4B	14.8B	-6.00%	-14.25%	7.67	1.38	2.12%	209.17%
MID-CAP
ATR	9.5B	3.5B	-0.91%	22.96%	30.27	2.67	6.16%	35.06%
HSIC	9.4B	12.3B	-2.70%	-9.94%	22.59	0.76	-2.44%	-22.68%
BIO	8.1B	2.7B	-21.14%	-36.84%	-12.64	3.01	-4.68%	82.43%
XRAY	6.3B	4.0B	-8.20%	-26.06%	-47.15	1.6	1.10%	85.84%
AXNX	3.4B	366.4M	-3.27%	17.57%	-560.12	9.28	33.86%	89.83%
PDCO	2.3B	6.6B	-7.27%	-4.94%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-12.41%	-15.32%	-1.95	0.41	7.73%	-1066.14%
ANIK	379.4M	166.7M	0.04%	-0.97%	-4.59	2.28	6.67%	-456.34%
ANGO	232.3M	324.0M	1.75%	-30.04%	-1.21	0.72	-3.19%	-337.41%
APYX	49.9M	52.3M	2.13%	-52.32%	-2.67	0.95	17.61%	19.28%
AEMD	3.6M	3.7M	-20.47%	240.00%	-0.29	0.95	5.77%	8.23%

ProSomnus, Inc. News

Latest updates

ProSomnus, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)									(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Revenue	10.8%	7,838,265	7,071,445	6,933,910	5,808,380	5,791,969	4,997,979	4,859,909	3,743,143	-
Cost Of Revenue	15.5%	4,133,502	3,580,073	3,170,794	2,756,631	2,686,525	2,540,288	2,321,692	1,578,496	-
Gross Profit	-100.0%	-	3,491,372	3,763,116	3,051,749	3,105,450	2,457,691	2,538,217	2,164,647	-
Costs and Expenses	190.1%	22,355,650	7,707,448	9,498,878	-	-	4,584,951	3,971,894	-	-
Operating Expenses	-	-	-	-	7,196,024	-	-	-	4,028,787	-
S&GA Expenses	4.2%	3,377,723	3,240,511	3,642,718	2,824,048	2,414,827	2,319,362	2,013,392	2,117,419	-
R&D Expenses	31.4%	1,366,930	1,040,065	1,376,036	1,018,969	1,065,479	688,540	669,348	557,633	-
EBITDA Margin	-0.7%	-0.31	-0.31	-0.02	-0.20	-0.03	-0.11	-0.11	-0.12	-0.14
Interest Expenses	-0.6%	1,480,745	1,489,286	1,240,159	1,171,810	2,405,224	1,421,702	1,197,237	1,095,837	-
Income Taxes	-	-	-	-	-	-	-1,172	3,567	4,085	-
Earnings Before Taxes	100.0%	-	-11,238,803	904,930	-6,892,171	2,208,020	-3,548,962	-2,823,645	-2,980,733	-
EBT Margin	7.4%	-0.54	-0.59	-0.31	-0.52	-0.37	-0.33	-0.36	-0.39	-0.42
Net Income	38.9%	-6,868,956	-11,238,803	904,930	-6,892,171	2,208,340	-3,548,962	-2,823,645	-2,980,733	-5,820,255
Net Income Margin	-48.6%	-0.87	-0.59	-0.31	-0.52	-0.37	-0.84	-0.70	-0.58	-0.42
Free Cashflow	-67.0%	-5,375,195	-3,218,027	-4,933,844	-4,066,934	-6,499,233	-1,574,229	-1,927,294	-1,592,244	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet							(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2021Q4
Assets	-13.5%	26.00	30.00	25.00	29.00	33.00	29.00	8.00
Current Assets	-19.0%	14.00	18.00	12.00	17.00	21.00	29.00	4.00
Cash Equivalents	-46.8%	6.00	12.00	6.00	12.00	16.00	2.00	2.00
Inventory	23.6%	2.00	2.00	1.00	1.00	1.00	-	0.00
Net PPE	-10.2%	3.00	4.00	3.00	3.00	2.00	-	3.00
Liabilities	1.5%	53.00	52.00	51.00	56.00	54.00	38.00	22.00
Current Liabilities	23.9%	14.00	12.00	9.00	8.00	7.00	1.00	7.00
Long Term Debt	-8.5%	12.00	13.00	13.00	14.00	14.00	-	-
LT Debt, Non Current	-8.5%	12.00	13.00	13.00	14.00	14.00	-	-
Retained Earnings	-3.0%	-234	-228	-216	-217	-210	-0.39	-203
Additional Paid-In Capital	1.1%	197	195	191	191	190	0.00	150
Shares Outstanding	6.8%	17.00	16.00	16.00	16.00	16.00	25.00	25.00
Float	-	-	-	26.00	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)										(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3
Cashflow From Operations	-130.0%	-5,811	-2,526	-4,696	-3,092	-5,476	-1,475	-1,824	-1,462	-	-
Share Based Compensation	214.3%	461	147	343	226	2,152	1.00	-	-	-	-
Cashflow From Investing	163.1%	436	-691	-237	-974	-1,022	-99.04	-102	-129	-	-
Cashflow From Financing	-95.4%	416	9,064	-450	-288	20,255	2,568	1,428	1,758	-	-

OSA Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 27,652	$ 19,393
Operating expenses:
Cost of revenue	13,641	9,127
Sales and marketing	13,085	8,865
General and administrative	15,230	9,895
Research and development	4,802	2,981
Total operating expenses	46,758	30,868
Net loss from operations	(19,106)	(11,475)
Other income (expense)
Interest expense, net	(5,382)	(6,120)
Change in fair value of earnout liability	12,190	9,260
Change in fair value of debt	1,328	553
Change in fair value of warrant liability	1,896	3,237
Loss on debt extinguishment	(10,450)	(2,598)
Other financing expense	(2,473)
Other expense, net	(2,098)	(2)
Total other income (expense), net	(4,989)	4,330
Net loss and comprehensive loss	$ (24,095)	$ (7,145)
Net loss per share attributable to common stockholders, basic	$ (1.49)	$ (0.71)
Net loss per share attributable to common stockholders, diluted	$ (1.49)	$ (0.71)
Weighted average shares of Common Stock, basic	16,177	10,022
Weighted average shares of Common Stock, diluted	16,177	10,022

OSA Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 6,363	$ 15,916
Restricted cash	700
Accounts receivable, net	3,839	2,843
Inventory	2,039	640
Prepaid expenses and other current assets	1,369	1,851
Total current assets	14,310	21,250
Property and equipment, net	3,358	2,404
Finance lease right-of-use assets	3,265	3,650
Operating lease right-of-use assets	5,069	5,633
Other assets	285	263
Total assets	26,287	33,200
Current liabilities:
Accounts payable	4,047	2,102
Accrued expenses and other current liabilities	6,756	3,706
Equipment financing obligation	57	59
Finance lease liabilities	1,052	1,009
Operating lease liabilities	304	215
Senior Convertible Notes at fair value, current portion	2,125
Total current liabilities	14,341	7,091
Equipment financing obligation, net of current portion	129	186
Finance lease liabilities, net of current portion	2,009	2,081
Operating lease liabilities, net of current portion	5,221	5,526
Senior Convertible Notes at fair value, net of current portion	12,152	13,651
Subordinated Convertible Notes at fair value	18,320	10,356
Earnout and warrant liability	716	14,802
Total liabilities	52,888	53,693
Commitments and contingencies
Stockholders' deficit:
Common Stock, $0.0001 par value, 150,000,000 and 100,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively; 17,388,599 and 16,041,464 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	2	2
Additional paid-in capital	196,731	190,299
Accumulated deficit	(234,889)	(210,794)
Total stockholders' deficit	(38,156)	(20,493)
Total liabilities, redeemable convertible preferred stock and stockholders' deficit	26,287	33,200
Redeemable Convertible Preferred Stock Subjected To Redemption
Current liabilities:
Redeemable Convertible Series A Preferred Stock, $0.0001 par value, stated value $1,000; 25,000 shares designated at December 31, 2023; 9,436 shares issued and outstanding at December 31, 2023; liquidation preference of $14,154 at December 31, 2023; No shares authorized, issued or outstanding at December 31, 2022	11,555
Preferred Stock Not Subjected To Redemption
Stockholders' deficit:
Preferred stock, $0.0001 par value, 1,475,000 and 1,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively; no shares issued or outstanding

About ProSomnus, Inc.

ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolarygologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.

CEO	Mr. Leonard Liptak
WEBSITE	prosomnus.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	129

ProSomnus, Inc. Frequently Asked Questions

What is the ticker symbol for ProSomnus, Inc.? What does OSA stand for in stocks?

OSA is the stock ticker symbol of ProSomnus, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ProSomnus, Inc. (OSA)?

As of Thu Apr 25 2024, market cap of ProSomnus, Inc. is 2.44 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OSA stock?

You can check OSA's fair value in chart for subscribers.

What is the fair value of OSA stock?

You can check OSA's fair value in chart for subscribers. The fair value of ProSomnus, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of ProSomnus, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for OSA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is ProSomnus, Inc. a good stock to buy?

The fair value guage provides a quick view whether OSA is over valued or under valued. Whether ProSomnus, Inc. is cheap or expensive depends on the assumptions which impact ProSomnus, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OSA.

What is ProSomnus, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 25 2024, OSA's PE ratio (Price to Earnings) is -0.1 and Price to Sales (PS) ratio is 0.09. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OSA PE ratio will change depending on the future growth rate expectations of investors.